AQUIPTA 10 mg tablets

Licence status
Authorised: 11/08/2023
Active substances
Atogepant monohydrate
Dosage Form
Tablet
Licence number
EU/1/23/1750/001-002
Licence holder
AbbVie Deutschland GmbH & Co. KG

Product documents

Licence information

ATC code
N02C ANTIMIGRAINE PREPARATIONS, N02CD07 atogepant
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
11/08/2023